Subsidiary Guarantors for 2036 Notes Subsidiary Guarantors for 2036 Notes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 29, 2016	Jul. 31, 2015	Jul. 29, 2016	Jul. 31, 2015	Jul. 29, 2016	Apr. 29, 2016	Oct. 30, 2015	Jul. 31, 2015	May 01, 2015	Oct. 31, 2014
Condensed Consolidating Statement of Income
Net sales	$ 586,552	$ 792,183	$ 1,714,837	$ 2,306,579
Cost of sales	454,594	574,838	1,351,329	1,668,633
Product development, selling and administrative expenses	114,377	128,553	341,433	390,089
Restructuring expenses	24,431	7,775	84,484	19,550
Other (income) expense	(1,681)	(1,234)	(7,828)	(5,347)
Operating (loss) income	(5,169)	82,251	(54,581)	233,654
Intercompany items	0	0	0	0
Interest (expense) income, net	(11,107)	(13,676)	(34,802)	(39,905)
(Loss) income before income taxes	(16,276)	68,575	(89,383)	193,749
(Benefit) provision for income taxes	(16,404)	17,239	(33,985)	55,930
Equity in income of subsidiaries	0	0	0	0
Net income (loss) from continuing operations	128	51,336	(55,398)	137,819
Comprehensive (loss) income	(13,032)	13,862	(57,692)	(8,553)
Current assets:
Cash and cash equivalents	182,825	140,900	102,885	270,191	$ 182,825		$ 102,885	$ 140,900		$ 270,191
Accounts receivable, net					647,017		812,073
Inventories					896,257		1,007,925
Other current assets					91,400		145,559
Assets held for sale					33,724		0
Total current assets					1,851,223		2,068,442
Property, plant and equipment, net					673,943		792,032
Other assets:
Other intangible assets, net					229,703		255,710
Goodwill					350,740		354,621
Deferred income taxes					202,463		118,913
Other non-current assets					125,345		122,728
Total other assets					908,251		851,972
Total assets					3,433,417		3,712,446
Current liabilities:
Short-term borrowings, including current portion of long-term obligations					32,545		26,321
Trade accounts payable					231,713		275,789
Employee compensation and benefits					76,340		90,335
Advance payments and progress billings					197,437		229,470
Accrued warranties					41,288	$ 46,981	52,146	55,603	$ 58,194	67,272
Other accrued liabilities					209,869		225,277
Current liabilities of discontinued operations					0		11,582
Total current liabilities					789,192		910,920
Long-term obligations					974,247		1,060,643
Other liabilities:
Liabilities for postretirement benefits					17,546		19,540
Accrued pension costs					160,894		175,699
Other non-current liabilities					118,692		125,635
Total other liabilities					297,132		320,874
Shareholders’ equity					1,372,846		1,420,009
Total liabilities and shareholders’ equity					3,433,417		3,712,446
Operating Activities:
Net cash provided (used) by operating activities			178,783	168,714
Investing Activities:
Acquisition of business, net of cash acquired			0	(114,353)
Property, plant and equipment acquired	(10,890)	(18,026)	(31,984)	(57,821)
Proceeds from sale of property, plant and equipment			20,078	4,071
Other investing activities, net			184	625
Net cash used by investing activities			(11,722)	(167,478)
Financing Activities:
Common stock issued			0	2,853
Dividends paid			(2,972)	(58,456)
Repayments of term loan			(18,750)	0
Payments on credit agreement			(58,600)	0
Repayments of short-term debt			(3,214)	(11,545)
Treasury stock purchased			0	(50,000)
Financing fees			(1,011)	0
Other financing activities, net			0	261
Net cash used by financing activities			(84,547)	(116,887)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			(2,574)	(13,640)
Increase (Decrease) in Cash and Cash Equivalents			79,940	(129,291)
Cash and Cash Equivalents at Beginning of Period			102,885	270,191
Cash and Cash Equivalents at End of Period	182,825	140,900	182,825	140,900
Eliminations
Condensed Consolidating Statement of Income
Net sales		(249,663)
Cost of sales		(193,736)
Product development, selling and administrative expenses		0
Restructuring expenses		0
Other (income) expense		0
Operating (loss) income		(55,927)
Intercompany items		20,260
Interest (expense) income, net		0
(Loss) income before income taxes		(35,667)
(Benefit) provision for income taxes		0
Equity in income of subsidiaries		(83,108)
Net income (loss) from continuing operations		(118,775)
Comprehensive (loss) income		(82,577)
6.625% Senior Notes due 2036 | Parent Company
Current assets:
Cash and cash equivalents	20,584	25,138	581	54,874	20,584		581	25,138		54,874
Operating Activities:
Net cash provided (used) by operating activities			101,711	76,032
Investing Activities:
Acquisition of business, net of cash acquired				0
Property, plant and equipment acquired			(559)	(141)
Proceeds from sale of property, plant and equipment			0	942
Other investing activities, net			184	(1,227)
Net cash used by investing activities			(375)	(426)
Financing Activities:
Common stock issued				2,853
Dividends paid			(2,972)	(58,456)
Repayments of term loan			(18,750)
Payments on credit agreement			(58,600)
Repayments of short-term debt			0	0
Treasury stock purchased				(50,000)
Financing fees			(1,011)
Other financing activities, net				261
Net cash used by financing activities			(81,333)	(105,342)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			0	0
Increase (Decrease) in Cash and Cash Equivalents			20,003	(29,736)
Cash and Cash Equivalents at Beginning of Period			581	54,874
Cash and Cash Equivalents at End of Period	20,584	25,138	20,584	25,138
6.625% Senior Notes due 2036 | Supplemental Subsidiary Guarantors
Current assets:
Cash and cash equivalents	4,384	2,462	2,008	16,429	4,384		2,008	2,462		16,429
Operating Activities:
Net cash provided (used) by operating activities			(3,400)	14,882
Investing Activities:
Acquisition of business, net of cash acquired				0
Property, plant and equipment acquired			(7,538)	(17,429)
Proceeds from sale of property, plant and equipment			13,314	214
Other investing activities, net			0	0
Net cash used by investing activities			5,776	(17,215)
Financing Activities:
Common stock issued				0
Dividends paid			0	0
Repayments of term loan			0
Payments on credit agreement			0
Repayments of short-term debt			0	(11,634)
Treasury stock purchased				0
Financing fees			0
Other financing activities, net				0
Net cash used by financing activities			0	(11,634)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			0	0
Increase (Decrease) in Cash and Cash Equivalents			2,376	(13,967)
Cash and Cash Equivalents at Beginning of Period			2,008	16,429
Cash and Cash Equivalents at End of Period	4,384	2,462	4,384	2,462
6.625% Senior Notes due 2036 | Supplemental Non-Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	157,857	113,300	100,296	198,888	157,857		100,296	$ 113,300		$ 198,888
Operating Activities:
Net cash provided (used) by operating activities			80,472	77,800
Investing Activities:
Acquisition of business, net of cash acquired				(114,353)
Property, plant and equipment acquired			(23,887)	(40,251)
Proceeds from sale of property, plant and equipment			6,764	2,915
Other investing activities, net			0	1,852
Net cash used by investing activities			(17,123)	(149,837)
Financing Activities:
Common stock issued				0
Dividends paid			0	0
Repayments of term loan			0
Payments on credit agreement			0
Repayments of short-term debt			(3,214)	89
Treasury stock purchased				0
Financing fees			0
Other financing activities, net				0
Net cash used by financing activities			(3,214)	89
Effect of Exchange Rate Changes on Cash and Cash Equivalents			(2,574)	(13,640)
Increase (Decrease) in Cash and Cash Equivalents			57,561	(85,588)
Cash and Cash Equivalents at Beginning of Period			100,296	198,888
Cash and Cash Equivalents at End of Period	157,857	113,300	157,857	113,300
6.625% Senior Notes due 2036 | Reportable Legal Entities | Parent Company
Condensed Consolidating Statement of Income
Net sales	0	0	0	0
Cost of sales	0	0	0	(6,354)
Product development, selling and administrative expenses	12,195	12,294	31,642	35,544
Restructuring expenses	0	0	395	252
Other (income) expense	0	0	0	68
Operating (loss) income	(12,195)	(12,294)	(32,037)	(29,510)
Intercompany items	13,466	16,750	43,729	50,106
Interest (expense) income, net	(12,252)	(16,068)	(37,552)	(47,449)
(Loss) income before income taxes	(10,981)	(11,612)	(25,860)	(26,853)
(Benefit) provision for income taxes	(8,012)	(6,218)	(24,165)	7,920
Equity in income of subsidiaries	3,097	56,730	(48,237)	172,592
Net income (loss) from continuing operations	128	51,336	(49,932)	137,819
Comprehensive (loss) income	(13,032)	13,862	(57,692)	(8,553)
Current assets:
Cash and cash equivalents	20,584		581		20,584		581
Accounts receivable, net					0		0
Inventories					0		0
Other current assets					7,129		58,441
Assets held for sale					0
Total current assets					27,713		59,022
Property, plant and equipment, net					19,193		21,318
Other assets:
Other intangible assets, net					0		0
Goodwill					0		0
Deferred income taxes					153,869		49,660
Other non-current assets					2,437,379		2,740,518
Total other assets					2,591,248		2,790,178
Total assets					2,638,154		2,870,518
Current liabilities:
Short-term borrowings, including current portion of long-term obligations					28,125		18,750
Trade accounts payable					2,238		3,342
Employee compensation and benefits					6,445		5,843
Advance payments and progress billings					0		0
Accrued warranties					0		0
Other accrued liabilities					90,009		76,650
Current liabilities of discontinued operations					0		0
Total current liabilities					126,817		104,585
Long-term obligations					974,202		1,060,598
Other liabilities:
Liabilities for postretirement benefits					17,546		18,662
Accrued pension costs					160,894		159,594
Other non-current liabilities					(14,151)		81,595
Total other liabilities					164,289		259,851
Shareholders’ equity					1,372,846		1,445,484
Total liabilities and shareholders’ equity					2,638,154		2,870,518
Financing Activities:
Cash and Cash Equivalents at Beginning of Period			581
Cash and Cash Equivalents at End of Period	20,584		20,584
6.625% Senior Notes due 2036 | Reportable Legal Entities | Supplemental Subsidiary Guarantors
Condensed Consolidating Statement of Income
Net sales	296,926	432,882	857,961	1,405,663
Cost of sales	251,950	322,255	723,843	1,032,345
Product development, selling and administrative expenses	47,345	51,788	134,775	161,298
Restructuring expenses	12,563	7,294	39,760	13,134
Other (income) expense	3,421	3,769	4,567	12,863
Operating (loss) income	(18,353)	47,776	(44,984)	186,023
Intercompany items	(14,173)	(30,145)	(206,525)	(75,362)
Interest (expense) income, net	581	1,863	1,056	4,999
(Loss) income before income taxes	(31,945)	19,494	(250,453)	115,660
(Benefit) provision for income taxes	(11,660)	997	(20,989)	25,488
Equity in income of subsidiaries	12,128	26,378	144,812	41,747
Net income (loss) from continuing operations	(8,157)	44,875	(84,652)	131,919
Comprehensive (loss) income	(7,958)	46,066	(84,137)	132,795
Current assets:
Cash and cash equivalents	4,384		2,008		4,384		2,008
Accounts receivable, net					140,809		214,381
Inventories					410,176		508,774
Other current assets					11,615		15,610
Assets held for sale					33,547
Total current assets					600,531		740,773
Property, plant and equipment, net					223,938		297,476
Other assets:
Other intangible assets, net					190,987		207,891
Goodwill					342,643		346,348
Deferred income taxes					0		0
Other non-current assets					1,891,233		2,078,294
Total other assets					2,424,863		2,632,533
Total assets					3,249,332		3,670,782
Current liabilities:
Short-term borrowings, including current portion of long-term obligations					0		0
Trade accounts payable					80,289		96,891
Employee compensation and benefits					26,308		36,527
Advance payments and progress billings					71,227		100,312
Accrued warranties					13,322		19,027
Other accrued liabilities					55,465		60,228
Current liabilities of discontinued operations					0		11,582
Total current liabilities					246,611		324,567
Long-term obligations					0		0
Other liabilities:
Liabilities for postretirement benefits					0		878
Accrued pension costs					0		8,406
Other non-current liabilities					10,439		8,325
Total other liabilities					10,439		17,609
Shareholders’ equity					2,992,283		3,328,606
Total liabilities and shareholders’ equity					3,249,333		3,670,782
Financing Activities:
Cash and Cash Equivalents at Beginning of Period			2,008
Cash and Cash Equivalents at End of Period	4,384		4,384
6.625% Senior Notes due 2036 | Reportable Legal Entities | Supplemental Non-Guarantor Subsidiaries
Condensed Consolidating Statement of Income
Net sales	468,787	608,964	1,355,613	1,611,037
Cost of sales	346,204	446,319	1,021,157	1,186,093
Product development, selling and administrative expenses	55,521	64,471	175,700	193,247
Restructuring expenses	11,868	481	44,329	6,164
Other (income) expense	(5,102)	(5,003)	(12,395)	(18,278)
Operating (loss) income	60,296	102,696	126,822	243,811
Intercompany items	(18,071)	(6,865)	117,833	(35,306)
Interest (expense) income, net	564	529	1,694	2,545
(Loss) income before income taxes	42,789	96,360	246,349	211,050
(Benefit) provision for income taxes	3,268	22,460	11,169	22,522
Equity in income of subsidiaries	0	0	0	0
Net income (loss) from continuing operations	39,521	73,900	235,180	188,528
Comprehensive (loss) income	38,834	$ 36,511	247,251	43,978
Current assets:
Cash and cash equivalents	157,857		100,296		157,857		100,296
Accounts receivable, net					516,797		597,826
Inventories					574,559		607,461
Other current assets					72,656		71,508
Assets held for sale					177
Total current assets					1,322,046		1,377,091
Property, plant and equipment, net					435,827		478,253
Other assets:
Other intangible assets, net					38,716		47,819
Goodwill					8,097		8,273
Deferred income taxes					48,594		69,253
Other non-current assets					3,149,707		2,517,110
Total other assets					3,245,114		2,642,455
Total assets					5,002,987		4,497,799
Current liabilities:
Short-term borrowings, including current portion of long-term obligations					4,420		7,571
Trade accounts payable					149,186		175,556
Employee compensation and benefits					43,587		47,965
Advance payments and progress billings					136,242		149,795
Accrued warranties					27,966		33,119
Other accrued liabilities					71,551		100,660
Current liabilities of discontinued operations					0		0
Total current liabilities					432,952		514,666
Long-term obligations					45		45
Other liabilities:
Liabilities for postretirement benefits					0		0
Accrued pension costs					0		7,699
Other non-current liabilities					122,404		35,715
Total other liabilities					122,404		43,414
Shareholders’ equity					4,447,585		3,939,674
Total liabilities and shareholders’ equity					5,002,986		4,497,799
Financing Activities:
Cash and Cash Equivalents at Beginning of Period			100,296
Cash and Cash Equivalents at End of Period	157,857		157,857
6.625% Senior Notes due 2036 | Eliminations
Condensed Consolidating Statement of Income
Net sales	(179,161)		(498,737)	(710,121)
Cost of sales	(143,560)		(393,671)	(543,451)
Product development, selling and administrative expenses	(684)		(684)	0
Restructuring expenses	0		0	0
Other (income) expense	0		0	0
Operating (loss) income	(34,917)		(104,382)	(166,670)
Intercompany items	18,778		44,963	60,562
Interest (expense) income, net	0		0	0
(Loss) income before income taxes	(16,139)		(59,419)	(106,108)
(Benefit) provision for income taxes	0		0	0
Equity in income of subsidiaries	(15,225)		(96,575)	(214,339)
Net income (loss) from continuing operations	(31,364)		(155,994)	(320,447)
Comprehensive (loss) income	(30,876)		(163,114)	$ (176,773)
Current assets:
Cash and cash equivalents	0		0		0		0
Accounts receivable, net					(10,589)		(134)
Inventories					(88,478)		(108,310)
Other current assets					0		0
Assets held for sale					0
Total current assets					(99,067)		(108,444)
Property, plant and equipment, net					(5,015)		(5,015)
Other assets:
Other intangible assets, net					0		0
Goodwill					0		0
Deferred income taxes					0		0
Other non-current assets					(7,352,974)		(7,213,194)
Total other assets					(7,352,974)		(7,213,194)
Total assets					(7,457,056)		(7,326,653)
Current liabilities:
Short-term borrowings, including current portion of long-term obligations					0		0
Trade accounts payable					0		0
Employee compensation and benefits					0		0
Advance payments and progress billings					(10,032)		(20,637)
Accrued warranties					0		0
Other accrued liabilities					(7,156)		(12,261)
Current liabilities of discontinued operations					0		0
Total current liabilities					(17,188)		(32,898)
Long-term obligations					0		0
Other liabilities:
Liabilities for postretirement benefits					0		0
Accrued pension costs					0		0
Other non-current liabilities					0		0
Total other liabilities					0		0
Shareholders’ equity					(7,439,868)		(7,293,755)
Total liabilities and shareholders’ equity					$ (7,457,056)		$ (7,326,653)
Financing Activities:
Cash and Cash Equivalents at Beginning of Period			0
Cash and Cash Equivalents at End of Period	$ 0		$ 0